BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7571966)

  • 1. Effusion cytology of hepatocellular carcinoma.
    Falconieri G; Zanconati F; Colautti I; Dudine S; Bonifacio-Gori D; Di Bonito L
    Acta Cytol; 1995; 39(5):893-7. PubMed ID: 7571966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytopathology of exocrine pancreatic carcinoma in effusions.
    Di Bonito L; Dudine S; Falconieri G
    Acta Cytol; 1991; 35(3):311-4. PubMed ID: 1710404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytology of hepatocellular carcinoma in serous fluids: a report of three cases.
    Rosendale BE; Dusenbery D
    Diagn Cytopathol; 1996 Aug; 15(2):127-31. PubMed ID: 8872435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diagnostic yield of pleural fluid cytology in malignant pleural effusions.
    Ong KC; Indumathi V; Poh WT; Ong YY
    Singapore Med J; 2000 Jan; 41(1):19-23. PubMed ID: 10783675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Significance of combining detection of E-cadherin, carcinoembryonic antigen, and calretinin in cytological differential diagnosis of serous effusion].
    Su XY; Li GD; Liu HB; Jiang LL
    Ai Zheng; 2004 Oct; 23(10):1185-9. PubMed ID: 15473932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytological study of serous effusions with the aid of tumour markers.
    Ray K; Mittal S; Gupta H; Jain M
    J Indian Med Assoc; 1999 Jan; 97(1):11-2, 19. PubMed ID: 10549179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serous effusions in malignant lymphomas: a review.
    Das DK
    Diagn Cytopathol; 2006 May; 34(5):335-47. PubMed ID: 16604559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of immunohistochemistry staining and cytologic diagnosis by using cell block sections prepared with effusion fluid cytology specimens].
    Mao YY; Yang M; Liu DG; Lin MH; Zhang LQ; Chen ZQ
    Zhonghua Bing Li Xue Za Zhi; 2009 Aug; 38(8):547-50. PubMed ID: 20021967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fractal dimension of cell clusters in effusion cytology.
    Sharma N; Dey P
    Diagn Cytopathol; 2010 Dec; 38(12):866-8. PubMed ID: 20049967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytomorphological and immunocytochemical study of non-Hodgkin's lymphoma in pleural effusion and ascitic fluid.
    Das DK; Al-Juwaiser A; George SS; Francis IM; Sathar SS; Sheikh ZA; Shaheen A; Pathan SK; Haji BE; George J; Kapila K
    Cytopathology; 2007 Jun; 18(3):157-67. PubMed ID: 17488258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunochemical approach to clinical cytology by demonstration of tumor markers using enzyme-labeled antibody technic].
    Nishida K; Yamamoto T; Yoshioka K; Iida M; Miyagawa H; Yoshikawa T; Sugino S; Kondo M
    Gan No Rinsho; 1986 Jul; 32(8):895-9. PubMed ID: 2427754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunocytochemical panel for distinguishing between carcinoma and reactive mesothelial cells in body cavity fluids.
    Politi E; Kandaraki C; Apostolopoulou C; Kyritsi T; Koutselini H
    Diagn Cytopathol; 2005 Mar; 32(3):151-5. PubMed ID: 15690338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How many cytological examinations should be performed for the diagnosis of malignant biliary stricture via an endoscopic nasobiliary drainage tube?
    Uchida N; Kamada H; Ono M; Aritomo Y; Masaki T; Nakatsu T; Kuriyama S
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1501-4. PubMed ID: 18028351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diagnostic value of cytokeratins and carcinoembryonic antigen immunostaining in differentiating hepatocellular carcinomas from intrahepatic cholangiocarcinomas.
    Stroescu C; Herlea V; Dragnea A; Popescu I
    J Gastrointestin Liver Dis; 2006 Mar; 15(1):9-14. PubMed ID: 16680226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of computerized morphometric analysis in diagnosis of effusion specimens.
    Arora B; Setia S; Rekhi B
    Diagn Cytopathol; 2006 Oct; 34(10):670-5. PubMed ID: 16955473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of benign or malignant origin of ascites with combined indirect immunoperoxidase assays of carcinoembryonic antigen and lysozyme.
    Kyrkou KA; Iatridis SG; Athanassiadou PP; Emmanouilidou AG; Athanassiadis PP
    Acta Cytol; 1985; 29(1):57-62. PubMed ID: 3881880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor activity in pleural and peritoneal effusions from cancer and non-cancer patients.
    Sairenji M; Suzuki K; Murakami K; Motohashi H; Okamoto T; Umeda M
    Jpn J Cancer Res; 1987 Aug; 78(8):814-8. PubMed ID: 3115927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis, PCNA and p53 in hepatocellular carcinoma.
    Paiva C; Oshima CT; Lanzoni VP; Forones NM
    Hepatogastroenterology; 2002; 49(46):1058-61. PubMed ID: 12143201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver cell dysplasia in liver cirrhosis and hepatocellular carcinoma.
    SzczepaƄski W
    Pol J Pathol; 1997; 48(3):147-57. PubMed ID: 9401407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular carcinoma of diffuse type: MR imaging findings and clinical manifestations.
    Kanematsu M; Semelka RC; Leonardou P; Mastropasqua M; Lee JK
    J Magn Reson Imaging; 2003 Aug; 18(2):189-95. PubMed ID: 12884331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.